Filing Details
Zura Bio Ltd (NASDAQ:ZURA) filed a Form 8-K with the Securities and Exchange Commission on August 17, 2026, disclosing a material event.
8k filedNASDAQ:ZURA
Zura Bio Ltd (ZURA) Reports Material Event to SEC
Zura Bio Ltd (NASDAQ:ZURA) filed a Form 8-K with the Securities and Exchange Commission on August 17, 2026, disclosing a material event.
At publication ·
What changed
Zura Bio Ltd (NASDAQ:ZURA) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Zura Bio Ltd filed a Form 8-K with the SEC on August 17, 2026, disclosing a material event that shareholders should be aware of, though the specific nature of the event is not detailed in this article.
- The company's stock trades at $5.68 with a market capitalization of $263.3 million as of the filing date.
- Form 8-K filings typically disclose significant events such as leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance between regular quarterly or annual reports.
Market Context
Zura Bio Ltd's stock currently trades at $5.68 with a market capitalization of $263.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Zura Bio Ltd's stock.
All SEC filings for Zura Bio Ltd are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ZURA Stock Page
Frequently Asked Questions
Where can I read ZURA's SEC filings?
Browse all filings on our ZURA SEC filings page.
What types of SEC filings does Zura Bio Ltd file?
Public companies like Zura Bio Ltd file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.